期刊文献+

The US Chinese Anti.Cancer Association and the Asian Fund for Cancer Research Recognize Young Chinese Cancer Researchers with the 2016 USCACA–AFCR scholar awards

The US Chinese Anti-Cancer Association and the Asian Fund for Cancer Research Recognize Young Chinese Cancer Researchers with the 2016 USCACA-AFCR scholar awards
下载PDF
导出
摘要 To foster and strengthen collaborations among cancer researchers and physicians in the United States (US) and China, the US Chinese Anti-Cancer Association (USCACA), the National Foundation for Cancer Research (NFCR), and the Asian Fund for Cancer Research (AFCR) have established the USCACA-NFCR/ AFCR Scholarship Program in Basic, Translational, and Clinical Studies. Between 2010 and 2015, 24 junior Chinese cancer researchers and physicians have been recognized by this award for their outstanding achievements in cancer research accomplished both during their training in the US and after their returning to China [1-4]. In 2016, three young researchers were selected on the basis of their significant contributions in translational cancer research.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2017年第4期172-175,共4页
关键词 CANCER Recognize States
  • 相关文献

二级参考文献22

  • 1Wang YM, Yang D, Cogdell D, Hu L, Xue FX, Broaddus R and Zhang W. Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma. Tech Cancer Res Treat, 2010,9(2):179-189.
  • 2Wang YM, Ji P, Liu J, Broaddus R, Xue FX and Zhang W. Centrosome-associated regulators of the GJM checkpoint as targets for cancer therapy. Mol Cancer, 2009,8:8.
  • 3wang Y, Xue F, Broaddus RR, Tao X, Xie SS and Zhu Y. Clinicopathological features in endometrial carcinoma associated with Lynch syndrome in China. lnt J Gynecol Cancer, 2009,19(4):651-656.
  • 4Wang WY, Wen J and Zhang W. MIIP as a cytoskeleton regulator that functions to block cell migration and invasion, delay mitosis, and suppress tumorigenesis, Curr Protein Pept Sci, 2011,12(1 ):68-73.
  • 5Song FF, Ji P, Zheng H, Song F J, Wang YM, Hao X, Wei Q, Zhang W and Chen K. Definition of a functional single nucleotide polymorphism in the cell migration inhibitory gene MIIP that affects the risk of breast cancer. Cancer Res, 2010,70(3):1024-1032.
  • 6Ji P, Smith SM, Wang YM, Jiang R, Song SW, Bruner J, Sawaya R, Kuan J, Yu HT, Fuller GN and Zhang W. Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP. Oncogene, 2010,29(24):3501-3508.
  • 7Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang YM, Cogdell D, Price ND, Pollock RE, Lazar AJF, Hunt KK, Trent JC and Zhang W. Intergrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug. Mol Cell Proteomics, 2010,9(11):2405-2413.
  • 8Zheng H, Song F J, Zhang L, Yang D, Ji P, Wang Y, AImeida M, Calin G, Hao X, Wei Q, Zhang W and Chen K. Genetic variants at the miR-124- binding site in the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. Int J Oncology, 2011,38 (4):1153- 1161.
  • 9Wang YM, Hu L, Ji P, Liu G, Liu Y, Cogdell D, Liu J, Broadus R, Xue FX and Zhang W. MIIP attenuates Racl/PAK1/cell migration signaling and decreases in expression in metastatic endometrial cancer. Oncogene, 2011. (Under revision).
  • 10Zhao Y, Liu H, Liu Z, et al. Overcoming trastuzumab resistance in ErbB2-positive breast cancer by targeting dysregulated glucose metabolism. Cancer Res, 2011,71:4585-4597.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部